← All diseases Metabolism and endocrine system

Systemic amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (28)Meta-analysis (4)Treatment guideline (4)Systematic review (11)Phase 3 study (8)Randomized trial (1)Clinical trial (192)Review article (235)Early study (phase 1 or 2) (17)Case report (283)Laboratory or animal study (21)Commentary or editorial (21) Studies currently recruiting participants only (30)

Filter

Publications and studies (1226)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Plasma cell neoplasms and related entities-evolution in diagnosis and classification. (2023/01/01) ♡
• Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study? (2023/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Systemic immunoglobulin light chain (AL) amyloidosis initially presenting as hematochezia: a case report. (2023/01/01) ♡
• Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloids and Amyloid-like Protein Aggregates in Foods: Challenges and New Perspectives. (2023/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies. (2023/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease (2023-12-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis (2023-11-15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis (2023-11-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population (2023-10-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis (2023-08-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis (2023-06-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation (2023-06-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis (2023-05-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients (2023-05-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD (2023-05-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis (2023-04-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers (2023-04-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis (2023-02-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis (2023-01-17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies. (2022/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Cardiac progression of systemic light chain amyloidosis]. (2022/12/31) ♡
• The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components. (2022/12/24) ♡
• Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis. (2022/12/22) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Deletion of the Alzheimer's disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice. (2022/12/22) ♡
• [Clinical Practice Guidelines for diagnosis of organic involvement of amyloidosis: Part 3/3 Year 2020]. (2022/12/21) ♡
• Breast Amyloidosis: A Case Report and Literature Review. (2022/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. (2022/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloid deposition at the carotid artery in an ATTRwt amyloidosis patient: a case report. (2022/12/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report. (2022/12/09) ♡
• Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country. (2022/12/05) ♡
• Cells coexpressing both myeloid and endothelial markers are detectable in the spleen and bone marrow of patients with primary myelofibrosis. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Renal manifestations in rheumatoid arthritis and spondylarthritis]. (2022/12/01) ♡
• Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myocardial Uptake of 68Ga-Pentixafor in a Patient With Systemic Amyloidosis. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current approaches to the diagnosis and management of amyloidosis. (2022/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloidosis in the nasopharynx and larynx: a case report. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primer on the Differential Diagnosis and Workup for Transthyretin Cardiac Amyloidosis. (2022/12/01) ♡
• Current Understanding of Systemic Amyloidosis and Underlying Disease Mechanisms. (2022/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of Pharmacist-Led Dementia Care Round Interventions on the Use of Sleep Medications. (2022/11/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Advances in the Treatment and Supportive Care of POEMS Syndrome. (2022/11/27) ♡
• Amyloid fibril structure from the vascular variant of systemic AA amyloidosis. (2022/11/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. POCUS Finding of Portal Venous Gas: An Unusual Consequence of an Amyloid Dysmotility Related Bezoar. (2022/11/21) ♡
• Cryo-EM structure of ex vivo fibrils associated with extreme AA amyloidosis prevalence in a cat shelter. (2022/11/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vitreous amyloidosis caused by a Lys55Asn variant in transthyretin: A case report. (2022/11/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Localized light chain amyloidosis: A self-limited plasmacytic B-cell lymphoproliferative disorder. (2022/11/15) ♡
• Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation. (2022/11/12) ♡
• Destruction of Lysozyme Amyloid Fibrils Induced by Magnetoferritin and Reconstructed Ferritin. (2022/11/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis. (2022/11/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. COVID-19 Exposure Unmasking Systemic Amyloidosis With Hepatic Predominance. (2022/11/04) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.